Assessment of TB47 as a potential novel therapeutic agent: <i>in vitro</i> and <i>in vivo</i> efficacy against <i>Mycobacterium leprae</i>. [PDF]
Furlan GHF +13 more
europepmc +1 more source
Anti-PGL-I seropositivity and development of leprosy in contacts: a comprehensive analysis of sociodemographic determinants, genetic susceptibility, and exposure characteristics to Mycobacterium leprae. [PDF]
Niitsuma ENA +4 more
europepmc +1 more source
<i>Mycobacterium leprae</i> Slide Positivity at Felege Hiwot Comprehensive Specialized Hospital, Northwest Ethiopia: Seven Years Retrospective Study. [PDF]
Erkihun M +11 more
europepmc +1 more source
Computational investigation of the global prevalence of multidrug resistant Mycobacterium leprae: A systematic review and meta-analysis. [PDF]
Zivarifar H, Ahrari F, Karbalaei M.
europepmc +1 more source
Challenges of the public health response to a rare case of non-autochthonous <i>Mycobacterium leprae</i>, Ireland, 2024. [PDF]
Marshall R +9 more
europepmc +1 more source
Unlocking Opportunities for Mycobacterium leprae and Mycobacterium ulcerans. [PDF]
Shyam M, Kumar S, Singh V.
europepmc +1 more source
Thermodynamic Determinants in Antibody-Free Nucleic Acid Lateral Flow Assays (AF-NALFA): Lessons from Molecular Detection of <i>Listeria monocytogenes</i>, <i>Mycobacterium leprae</i> and <i>Leishmania amazonensis</i>. [PDF]
Lopes-Luz L +7 more
europepmc +1 more source

